Medicine at Michigan
Medicine at Michigan
Medicine at Michigan About Current Issue Past Issues Contact Development and Alumni Relations
   
Spacer
Fall 2003
Departments
Dean's Letter
Letters
Above the Huron
Moments
Class Notes
CME
Limelight
Greenfield's Message
 
Credits
 
Ways to Give
   Magazine
   Keyword
  
                

 

 

Protein Governs Spread of Prostate Cancer

It's not usually prostate cancer itself that kills — it's the spread of the cancer from the prostate to the rest of the body. But relatively little is known about exactly what makes some men's cancers spread, or metastasize, while other tumors stay put. A new study by scientists at the University of Michigan Comprehensive Cancer Center has revealed one crucial key to that deadly process.

Zheng Fu and Evan Keller
Photo: D.C. Goings

The U-M team found that a protein called RKIP, for Raf kinase inhibitor protein, governs the ability of prostate cancer cells to leave their original location and enter nearby blood vessels, which then act as superhighways to the rest of the body.

The findings show that RKIP is vital to a process called vascular invasion, which is the first step in a cascade of events leading to metastasis. Tumors that produce a normal amount of RKIP appear unable to make the jump to the vascular system, reports Evan Keller, D.V.M., Ph.D., an associate professor of comparative medicine and of pathology in the U-M Medical School, who led the research study. But if a tumor cell lacks RKIP, metastasis can take place.

Keller notes that vascular invasion is not the only action required for cancer to spread. "Many cancer cells that enter the bloodstream don't go on to form successful metastases," he says. Keller predicts that the U-M discovery will help scientists and clinicians better understand the complex process by which some cancers kill.

The study was funded by the Stuart and Barbara Padnos Endowed Research Fund, the Association for the Cure of Cancer of the Prostate, the Department of Defense and the National Cancer Institute through the U-M's SPORE (Specialized Program in Research Excellence) grant for prostate cancer research. U-M research collaborators included Zheng Fu (Ph.D. 2002), U-M postdoctoral researcher; Rodney L. Dunn, a U-M research associate; and Zhi Yao, a U-M visiting professor.

-KG

 

Read an expanded version of the story:
www.med.umich.edu/opm/newspage/2003/prostateprotein.htm

Find more information on prostate cancer:
www.med.umich.edu/1libr/aha/aha_metprost_crs.htm
www.cancer.med.umich.edu/learn/pwprostate.htm

 

Previous

 

 

Features
Support
Scholarship Support
Spacer

 

Download PDF

 

 

 

Copyright 2003 University of Michigan Medical School

 

Spacer